Jean Binder
      OUR PEOPLE

      Dr. Jean Binder

      PhD in Global Project Management

      Head of Project Excellence and Governance

      Contact

      Jean is Head of Project Excellence and Governance at PMI and is the main point of contact and oversight for governance processes, best practices, and tools, providing end-to-end visibility on Life Sciences objectives, strategies, goals, and achievements. He holds a PhD in Global Project Management from Heriot-Watt University, U.K., and two Master's degrees in Project Management — one from George Washington University and the other from Ichec Brussels Management School.

      Jean started his career in 1987 with a strong focus on team and project management, and gained decades of experience managing IS, IT and biological research programs, projects and teams. Jean joined PMI in 2018 as a Manager Program Management Office, specializing in biomedical systems research.

      In addition to his vast working experience, Jean is also a lecturer on project management, presenting in global congresses and teaching at the University of Fribourg (iimt - Switzerland), University of Lausanne and at Norges Teknisk-Naturvitenskapelige Universitet (NTNU - Norway). Thus, Jean himself considers his biggest achievement to be supporting the career progression of the great professionals he has had the opportunity to work with.

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.